Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning
Open Access
- 21 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2), e55876
- https://doi.org/10.1371/journal.pone.0055876
Abstract
We analysed kinetics of IL-7 and IL-15 levels in 70 patients given peripheral blood stem cells after nonmyeloablative conditioning. EDTA-anticoagulated plasma and serum samples were obtained before conditioning and about once per week after transplantation until day 100. Samples were aliquoted and stored at −80°C within 3 hours after collection until measurement of cytokines. IL-7 and IL-15 levels were measured by ELISAs. Median IL-7 plasma levels remained below 6 pg/L throughout the first 100 days, although IL-7 plasma levels were significantly higher on days 7 (5.1 pg/mL, P = 0.002), 14 (5.2 pg/mL, P<0.001), and 28 (5.1 pg/mL, P = 0.03) (but not thereafter) than before transplantation (median value of 3.8 pg/mL). Median IL-15 serum levels were significantly higher on days 7 (12.5 pg/mL, P<0.001), 14 (10.5 pg/mL, P<0.001), and 28 (6.2 pg/mL, P<0.001) than before transplantation (median value of 2.4 pg/mL). Importantly, IL-7 and IL-15 levels on days 7 or 14 after transplantation did not predict grade II–IV acute GVHD. These data suggest that IL-7 and IL-15 levels remain relatively low after nonmyeloablative transplantation, and that IL-7 and IL-15 levels early after nonmyeloablative transplantation do not predict for acute GVHD.Keywords
This publication has 60 references indexed in Scilit:
- Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012
- Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesBlood, 2011
- IL-15 transpresentation promotes both human T-cell reconstitution and T-cell–dependent antibody responses in vivoProceedings of the National Academy of Sciences of the United States of America, 2011
- Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of ageHaematologica, 2010
- NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionTransplantation and Cellular Therapy, 2010
- Immune Reconstitution: How It Should Work, What's Broken, and Why It MattersTransplantation and Cellular Therapy, 2010
- What Is the Role for Donor Natural Killer Cells after Nonmyeloablative Conditioning?Transplantation and Cellular Therapy, 2009
- Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host DiseaseJournal of Clinical Oncology, 2008
- Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsThe Journal of Experimental Medicine, 2008
- Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current PerspectivesTransplantation and Cellular Therapy, 2007